Risk Assessment of Cytotoxicity of DNA Binding Proteins by Bach, Christian et al.
Risk assessment of Cytotoxicity of DNA 
binding proteins 
Christian Bach, Hassan Bajwa, Kris Erodula, Prabir Patra 
Department of Biomedical Engineering 
University of Bridgeport, Bridgeport, CT  
The Role of  Transcription Factors 
For clinical applications the biological functions 
of DNA-binding proteins require that they 
interact with their target binding site with high 
affinity and specificity. Advances in randomized 
production and target-oriented selection of 
engineered artificial DNA binding domains 
incited a rapidly expanding field of designer 
transcription factors (TFs). Zinc-finger binding 
domains fabricated via modular assembly display 
an unexpectedly high failure rate having either a 
lack of activity as ZNFs in human cells or 
activity at “off-target” binding sites on the human 
genome causing cell death. To address these 
shortcomings we created new binding domains 
using a targeted modification strategy. Instead of 
tethering single fingers together to assemble zinc 
finger binding domains, we exchanged amino 
acid residues in the alpha-helical region of the 
transcription factor Sp1. To illustrate the 
technique, we produced two Sp1 mutants and 
identified their best target binding sites. Our 
research concludes that the biological functions 
of DNA-binding proteins require factors and 
mechanisms beyond the ones of affinity and 
specificity.   
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 Figure 1: Three  finger of Sp1 binding domain 
and consensus binding site GGGGCGGGG 
If sequence specific DNA binding of a zinc 
finger is solely based on specificity and 
affinity (Cornu et al., 2007), but do not 
control engineered zinc fingers, Sp1 is prone 
to indiscriminately bind all twenty thousand 
identical consensus sequences 
(GGGGCGGGG) on the human genome and 
would probably cause some undesired 
interactions. Because Sp1 induced negative 
effects are not observed, leads us to the 
conclusion that other factors (besides 
specificity and affinity) and location specific 
mechanisms (besides sequence specific) that 
control recognition play a role. Three possible 
targets could be involved in controlling 
location specific binding of Sp1: 
 
1. Regulation of the whole zinc finger protein 
2. Regulation of the binding domain 
3. Regulation of the binding sites 
3finger/9bp Paradox and Paradigms of DNA/protein Interactions  
Figure 4: Three Three helical region of the  second sp1 finger, RSDELQRH, was replaced by the amino acids 
KSSALISH creating zinc finer mutant CB1 by performing PCR based site directed mutagenesis.  The non 
conserved amino acids, arginine (R), aspartic acid (D), glutamic acid (E), glutamine (Q) and arginine (E) at zinc 
finger positions 15,17,18,20 and 21, were replaced by lysine (K), serine (S), alanine (A), isoleucinc (D) and serine 
(S) (Thiesen et al. 1991).  Additional 30 sp1 MQ- and MR- mutants have been created. Recombinant mutated sp1 
proteins were purified by FPLC Mono S chromatography. The DNA binding activity of sp1 and mutated sp1 
proteins was assessed by incubating the 64 labeled double-stranded oligonucleotides (n = 3) with chimaeric proteins 
CB1 and MR14 and  performing electrophoretic mobility shift assays (EMSA) (Thiesen & Bach, 1991).  
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 Figure 2: Three  finger of CB1 binding domain 
and best binding site GGGCCCGGG 
 Figure 3: Three  finger of MR14 binding domain and 
best binding site GGGGAGGGG 
Sp1-mutants CB1 and MR14 
With site directed PCR mutagenesis (Thiesen & 
Bach, 1991) Sp1 mutants CB1 (Figure 4) and 
MR14 (Figure 5) were created. 
GGGGCGGGG     
(Sp1 consensus)
GGGCGGGGG 
(Sp1 Best)
GGGCCCGGG 
(CB1 Best) 
GGGGAGGGG 
(MR14 Best)
CGGCCCCAG      
(MA1 Best)
chr1 1667 1281 487 4461 392
chr2 1279 1077 360 3685 319
chr3 959 795 250 2857 219
chr4 703 561 199 2430 186
chr5 798 683 213 2620 198
chr6 918 783 216 2710 232
chr7 967 771 293 2586 290
chr8 722 575 192 2283 193
chr9 830 669 259 2173 226
chr10 822 634 260 2422 212
chr11 1078 758 311 2757 238
chr12 882 735 242 2421 207
chr13 422 337 100 1186 98
chr14 669 547 162 1609 141
chr15 553 429 175 1483 149
chr16 898 618 295 1779 255
chr17 1077 756 317 2203 286
chr18 352 294 103 1049 77
chr19 1555 887 445 2145 280
chr20 596 504 227 1418 149
chr21 244 182 91 595 79
ch22 567 420 196 1158 145
chX 757 624 161 2819 147
chY 30 21 4 119 7
Total 19345 14941 5558 50968 4725
Table 1: List of exact matches on each chromosome for each of the 9bp binding target sites of Sp1, CB1, MR14. 
Predominant Paradigms Complementary Paradigms 
1. Paradigm of equal functionality of each zinc finger  Paradigm of preservation of evolutionary trades inherent  in natural zinc fingers 
2. Paradigm of independency Paradigm of interdependency 
3. Paradigm of modular assembly Paradigm of targeted modifications 
4. Paradigm of randomness Paradigm of evolution 
5. Paradigm of overlap problem  Paradigm of precision 
6. Paradigm of best target sites Paradigm of complete recognition code 
7. Paradigm of clinical compatibility Paradigm of complete “off-target” cleavage pattern  
Conclusion 
Our results show that Sp1 has a robust three-dimensional structure and can be used for the 3x2 strategy (Klug, 2010). We propose to use 
targeted modification as strategy to gradually alter Sp1 to recognize new GC and AT rich target binding sites.  
The new binding domains were produced via a 
targeted modification strategy that differs from 
the modular assembly strategy in the way that 
instead of tethering single fingers together to 
assemble zinc finger arrays, we exchanged amino 
acid residues in the alpha-helical region of the 
transcription factor Sp1.  
Regulatory Cell Mechanisms  
Our findings indicate the existence of yet unknown regulatory mechanisms in the cell to control binding natural zinc fingers. It seems that such 
regulatory cell mechanisms do not function with artificial engineered zinc finger binding domains. This leads to the strong argument that with 
targeted modification of natural zinc fingers the function of the regulatory cell apparatus might be preserved and the apparatus would be 
functioning at new target binding sites. It also might require tagging new target sites with factors that are recognized by regulatory elements. 
We summarize our findings with seven predominant and seven complementary paradigms to help manufacture improved zinc finger proteins 
for clinical applications. 
Our findings shown in Figure 4 display the 
DNA recognition of the 2nd finger changes 
from GCG for Sp1 to CCC for CB1 and GAG 
for MR14. It indicates that the framework of 
the Sp1 binding domain has the structural 
stability and flexibility that can be employed 
for a targeted modification strategy.  
Table 2: List of  resulting paradigms. 
 
We further investigate the feasibility to use 
three finger binding domains for clinical 
applications because it is known that 
engineered three finger domains display 
cytotoxicity when used in zinc finger 
nuclease (ZNF). Cytotoxicity is linked to the 
ability of engineered DNA binding proteins to 
bind at the same or similar binding sites 
throughout the genome and exert influence on 
cells functions. Such binding events at “off-
target” sites can cause cell death (Cathomen, 
2009). We searched the NCBI HuRef genome 
for exact matches 3 finger / 9 base pair 
binding sites.  
The results are displayed in Table 1. We 
found a high frequency of nine base pair 
target binding sites for three finger binding 
domains throughout the human genome, 
which is a significant imbalance between the 
number of genes a natural zinc finger protein 
regulates and the actual number of locations 
that exist on the human genome. In the 
current predominant notion, affinity and 
specificity (E. J. Rebar & Pabo, 1994) are the 
factors that determine binding, which 
consequently means that Sp1 binds to nearly 
twenty thousand locations on the human 
genome.  
Alterations in 2nd finger of Sp1 
Figure 1 shows the three finger binding domain 
of Sp1. The underlined/blue amino acids 
represent the alpha-helical region in the second 
finger. Figure 2 and Figure 3 show the altered 
amino acids of CB1 and MR14 in italic/red.  
The 3finger/9bp Paradox 
A more feasible strategy for nature to avoid cytotoxicity would be the use of a six finger 
domain structure binding an eighteen base pair DNA sequence that with high probability 
occurs only a single time on the genome. Therefore, it is a 3finger/9bp paradox that the 
evolutionary process came up with a three finger domain solution that will bind to 5,000 – 
50,000 identical DNA sequences on the human genome. 
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